Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro

Leukemia Research

Volumn 31, Issue 3, 2007, Pages 315-320

  Hatzivassiliou, Eudoxia G ^a,b   Kieff, Elliott ^c   Mosialos, George ^a,b  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD40; LMP1; Lymphoma; NF B; Signal transduction; Transformation

Indexed keywords

CD40 ANTIGEN; LATENT MEMBRANE PROTEIN 1; ONCOPROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL TRANSFORMATION; CONTACT INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; FIBROBLAST; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VIRUS CARCINOGENESIS;

ANIMALS; ANTIGENS, CD40; CELL LINE; CELL TRANSFORMATION, VIRAL; CONTACT INHIBITION; FIBROBLASTS; ONCOGENE PROTEINS, VIRAL; PHENOTYPE; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

EID: 33846055029     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.06.023     Document Type: Article

References (17)

1. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4th ed. (2001), Lippinkott, Williams & Wilkins, Philadelphia, PA 2575
2. Kieff E., and Rickinson A. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4th ed (2001), Lippincott, Williams & Wilkins, Philadelphia, PA 2511
3. Wang D., Liebowitz D., and Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43 (1985) 831
4. Baichwal V.R., and Sugden B. Transformation of Balb/3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 4 (1988) 67
5. Kulwichit W., Edwards R.H., Davenport E.M., Baskar J.F., Godfrey V., and Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 95 (1998) 11963
6. Mainou B.A., Everly Jr. D.N., and Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24 October (2005) 6917
7. He Z., Xin B., Yang X., Chan C., and Cao L. Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts. Cancer Res 60 (2000) 1845
8. Lam N., and Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal 15 (2003) 9
9. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 16 (1997) 6131
10. Hatzivassiliou E., Miller W.E., Raab-Traub N., Kieff E., and Mosialos G. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappaB, and stress-activated protein kinase. J Immunol 160 (1998) 1116
11. Eliopoulos A.G., and Young L.S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16 (1998) 1731
12. Panagopoulos D., Victoratos P., Alexiou M., Kollias G., and Mosialos G. Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo. J Virol 78 December (2004) 13253
13. Miller W.E., Mosialos G., Kieff E., and Raab-Traub N. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol 71 (1997) 586
14. Hammerschmidt W., Sugden B., and Baichwal V.R. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 63 (1989) 2469
15. Eliopoulos A.G., and Young L.S. The role of the CD40 pathway in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4 August (2004) 360
16. Brown K.D., Hostager B.S., and Bishop G.A. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193 (2001) 943
17. Henriquez N.V., Floettmann E., Salmon M., Rowe M., and Rickinson A.B. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1. J Immunol 162 (1999) 3298